Isoquinoline-4-boronic acid → 4-((2-Phenylpyrimidin-5-yl)methyl)isoquinoline
Reaction equation
Br[CH2:2][C:3]1[CH:4]=[N:5][C:6]([C:9]2[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=2)=[N:7][CH:8]=1.[CH:15]1[C:24]2[C:19](=[CH:20][CH:21]=[CH:22][CH:23]=2)[C:18](B(O)O)=[CH:17][N:16]=1>>[C:9]1([C:6]2[N:5]=[CH:4][C:3]([CH2:2][C:18]3[C:19]4[C:24](=[CH:23][CH:22]=[CH:21][CH:20]=4)[CH:15]=[N:16][CH:17]=3)=[CH:8][N:7]=2)[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1Participants
Procedure
Synthesized using compound 64a (85 mg, 0.34 mmol) and isoquinolin-4-ylboronic acid (104 mg, 0.60 mmol) according to Method C. Crude product was purified by flash chromatography on silica-gel using a mixture of hexane/ethyl acetate (3:1) as eluent. After flash chromatography the product was solved in ethyl acetate and a few drops of conc. HCl and water were added. After stirring for 30 minutes the phases were separated and water phase was neutralized with aqueous Na2CO3-solution (2M). After extraction with ethyl acetate and drying over MgSO4 the solvent was removed under vacuum. Orange solid. Yield: 68 mg, 67%. 1H NMR (CDCl3, 500 MHz): δH (ppm)=4.40 (s, 2H), 7.44-7.51 (m, 3H), 7.61-7.67 (m, 1H), 7.67-7.74 (m, 1H), 7.87 (dd, J=8.4, 0.8 Hz, 1H), 8.02-8.06 (m, 1H), 8.37-8.42 (m, 2H), 8.49 (s, 1H), 8.66 (s, 2H), 9.24 (s, 1H); 13C NMR (CDCl3, 125 MHz): δC (ppm)=30.9, 122.8, 127.4, 127.5, 127.9, 128.6, 128.6, 128.6, 130.4, 130.6, 131.0, 134.3, 137.2, 143.6, 152.7, 157.0, 163.1; (ESI): m/z=297.91 [M+H]+.
Workup
- customSynthesized
- customCrude product was purified by flash chromatography on silica-gel
- additiona mixture of hexane/ethyl acetate (3:1) as eluent
- additiona few drops of conc. HCl and water were added
- customwere separated
- extractionAfter extraction with ethyl acetate
- dry with materialdrying over MgSO4 the solvent
- customwas removed under vacuum
Sources & evidence
- ORD record
- ord-310553eb9bf34773ba0153084c9b6891
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09394290B2
Reaction notes
Loading…